SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

  • Adam J. Bass
  • , Hideo Watanabe
  • , Craig H. Mermel
  • , Soyoung Yu
  • , Sven Perner
  • , Roel G. Verhaak
  • , So Young Kim
  • , Leslie Wardwell
  • , Pablo Tamayo
  • , Irit Gat-Viks
  • , Alex H. Ramos
  • , Michele S. Woo
  • , Barbara A. Weir
  • , Gad Getz
  • , Rameen Beroukhim
  • , Michael O'Kelly
  • , Amit Dutt
  • , Orit Rozenblatt-Rosen
  • , Piotr Dziunycz
  • , Justin Komisarof
    • Lucian R. Chirieac, Christopher J. Lafargue, Veit Scheble, Theresia Wilbertz, Changqing Ma, Shilpa Rao, Hiroshi Nakagawa, Douglas B. Stairs, Lin Lin, Thomas J. Giordano, Patrick Wagner, John D. Minna, Adi F. Gazdar, Chang Qi Zhu, Marcia S. Brose, Ivan Cecconello, Ulysses Ribeiro, Suely K. Marie, Olav Dahl, Ramesh A. Shivdasani, Ming Sound Tsao, Mark A. Rubin, Kwok K. Wong, Aviv Regev, William C. Hahn, David G. Beer, Anil K. Rustgi, Matthew Meyerson*
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

836 Scopus citations

Fingerprint

Dive into the research topics of 'SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology